Track COVID-19 Research and Clinical Trials in Real Time
Amplion is your partner
in the fight against COVID-19

As COVID-19 infections increase daily, organizations with technologies and services that can support new drug, vaccine, or test development have a life-saving contribution to make. As innovators, you need access to early, relevant information to arm yourselves in the fight against COVID-19.

For years, Amplion has helped companies make sense of the biomedical landscape and connect to collaborators in multiple disease areas, using our unique machine-learning software. Now we’ve leveraged that expertise to develop a customized interface that tracks the quickly evolving space of coronavirus pre-clinical and clinical trials, so you can find programs where your unique capabilities are needed.
Access COVID-19
Research Tracker








The Amplion Intelligence Platform Mutes the Noise to Give You Relevant COVID-19 Insights

 Identify Relevant Evidence Immediately

Machine-learning analysis of global research and clinical trial activity for all Coronavirus-related drug and vaccine trials so you can automatically find organizations to partner with.


  Alerts for New and Updated Research

Comprehensive analysis and insights targeting Coronavirus research and development across the globe, including biopharma, academia and hospital activity delivered to your inbox.


  Target New Drug Programs in Real Time

Early, in-depth analysis and continuous monitoring to identify drug programs as they progress through the development pipeline so you don’t miss critical events and are equipped to engage with partners at the right time.
PageLines